Table of Content




1. Executive Summary


2. Global RNA Analysis/Transcriptomics Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global RNA Analysis/Transcriptomics Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global RNA Analysis/Transcriptomics Market by Product Type
3.3.1: Consumables
3.3.2: Instruments
3.3.3: Software
3.3.4: Services


3.4: Global RNA Analysis/Transcriptomics Market by Technology
3.4.1: Real Time-PCR (qPCR)
3.4.2: Microarray
3.4.3: Sequencing
3.4.4: Others


3.5: Global RNA Analysis/Transcriptomics Market by Application
3.5.1: Drug Discovery
3.5.2: Diagnostics & Disease Profiling
3.5.3: Others

3.6: Global RNA Analysis/Transcriptomics Market by End Use
3.6.1: Government Institutes & Academic Centers
3.6.2: Pharmaceutical & Biotechnology
3.6.3: Hospitals & Clinics
3.6.4: Contract Research Organizations (CROs)
3.6.5: Others


4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global RNA Analysis/Transcriptomics Market by Region
4.2: North American RNA Analysis/Transcriptomics Market

4.2.1: North American RNA Analysis/Transcriptomics Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
4.2.2: North American RNA Analysis/Transcriptomics Market by End Use: Government Institutes & Academic Centers, Pharmaceutical & Biotechnology, Hospitals & Clinics, Contract Research Organizations (CROs), and Others

4.3: European RNA Analysis/Transcriptomics Market

4.3.1: European RNA Analysis/Transcriptomics Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
4.3.2: European RNA Analysis/Transcriptomics Market by End Use: Government Institutes & Academic Centers, Pharmaceutical & Biotechnology, Hospitals & Clinics, Contract Research Organizations (CROs), and Others

4.4: APAC RNA Analysis/Transcriptomics Market

4.4.1: APAC RNA Analysis/Transcriptomics Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
4.4.2: APAC RNA Analysis/Transcriptomics Market by End Use: Government Institutes & Academic Centers, Pharmaceutical & Biotechnology, Hospitals & Clinics, Contract Research Organizations (CROs), and Others

4.5: ROW RNA Analysis/Transcriptomics Market

4.5.1: ROW RNA Analysis/Transcriptomics Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
4.5.2: ROW RNA Analysis/Transcriptomics Market by End Use: Government Institutes & Academic Centers, Pharmaceutical & Biotechnology, Hospitals & Clinics, Contract Research Organizations (CROs), and Others


5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global RNA Analysis/Transcriptomics Market by Product Type
6.1.2: Growth Opportunities for the Global RNA Analysis/Transcriptomics Market by Technology
6.1.3: Growth Opportunities for the Global RNA Analysis/Transcriptomics Market by Application
6.1.4: Growth Opportunities for the Global RNA Analysis/Transcriptomics Market by End Use
6.1.5: Growth Opportunities for the Global RNA Analysis/Transcriptomics Market by Region

6.2: Emerging Trends in the Global RNA Analysis/Transcriptomics Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global RNA Analysis/Transcriptomics Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global RNA Analysis/Transcriptomics Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Agilent Technologies
7.2: F. Hoffmann-La Roche
7.3: Illumina
7.4: QIAGEN
7.5: Thermo Fisher Scientific
7.6: Eurofins Scientific
7.7: Merck KGaA
7.8: Bio-Rad Laboratories
7.9: Pacific Bioscience of California
7.10: Affymetrix